logo-loader
viewCircassia Pharmaceuticals PLC

Circassia Pharma Plc - Block listing Interim Review

RNS Number : 3559M
Circassia Pharmaceuticals Plc
13 September 2019
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date: 13 September 2019

 

Name of applicant:

Circassia Pharmaceuticals plc

Name of scheme:

Circassia EMI Share Option Scheme

Period of return:

From:

1st January 2019

To:

30th June 2019

Balance of unallotted securities under scheme(s) from previous return:

700,750

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

-

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

700,750

         

 

Name of applicant:

Circassia Pharmaceuticals plc

Name of scheme:

Circassia 2007 Unapproved Share Scheme

Period of return:

From:

1st January 2019

To:

30th June 2019

Balance of unallotted securities under scheme(s) from previous return:

203,000

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

-

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

203,000

         

 

 

Name of applicant:

Circassia Pharmaceuticals plc

Name of scheme:

Circassia 2014 Performance Share Plan Scheme

Period of return:

From:

1st January 2019

To:

30th June 2019

Balance of unallotted securities under scheme(s) from previous return:

83,414

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(6,738)

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

76,676

         

 

Name of applicant:

Circassia Pharmaceuticals plc

Name of scheme:

Circassia 2015 Performance Share Plan Scheme

Period of return:

From:

1st January 2019

To:

30th June 2019

Balance of unallotted securities under scheme(s) from previous return:

305,628

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(25,016)

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

280,612

         

 

  

 

Name of contact:

Julien Cotta

Telephone number of contact:

01865 405 560

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BLRGGUAABUPBGQW

Quick facts: Circassia Pharmaceuticals PLC

Price: 22.7

Market: LSE
Market Cap: £85.17 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Circassia Pharmaceuticals' commercial development...

Circassia Pharmaceuticals PLC's (LON:CIR) CEO Steve Harris tells Proactive London's Andrew Scott they saw strong growth in the first half of the year alongside a reduction in costs and cash outflows. Revenues for the six months ended June 30 were up 40% year-on-year at £27.9mln, with the...

on 26/9/19